Deal News

Ingersoll Rand to expand life science presence with $2.3bn ILC buyout

Ingersoll Rand has signed an agreement for the acquisition of ILC Dover from investment company New Mountain Capital for $2.325bn…

Nuvation Bio to acquire AnHeart to form global oncology company

Nuvation Bio has made a definitive agreement to acquire AnHeart Therapeutics through an all-stock transaction, in a strategic move to…

AbbVie signs agreement to acquire Landos Biopharma for $212.5m

AbbVie has entered a definitive agreement to acquire clinical-stage biopharmaceutical company Landos Biopharma for $212.5m. The strategic acquisition boosts AbbVie's…

Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline

Novo Nordisk has agreed to acquire Germany-based Cardior Pharmaceuticals for up to €1bn ($1.1bn) to expand its cardiovascular pipeline. The…

Gilead acquires CymaBay Therapeutics for $4.3bn

Gilead Sciences has concluded the acquisition of CymaBay Therapeutics for $4.3bn. The strategic move was finalised following the closure of…

Bristol Myers Squibb acquires Karuna Therapeutics for $14bn

Bristol Myers Squibb (BMS) has concluded the acquisition of biopharmaceutical company Karuna Therapeutics for $14bn in cash. The transaction was finalised…

AstraZeneca snaps up Amolyt for $1.05bn to boost rare disease pipeline

AstraZeneca has signed a definitive agreement to acquire Amolyt Pharma, which specialises in therapies for rare endocrine diseases, in a…

Novartis exercises option to acquire IFM Due for $835m

Novartis has exercised an option for the acquisition of all outstanding capital stock of IFM Therapeutics subsidiary IFM Due for…

Merck completes acquisition of Harpoon Therapeutics

Merck & Co. (MSD) has concluded the acquisition of Harpoon Therapeutics to broaden its oncology pipeline. In January 2024, MSD…

Johnson & Johnson acquires Ambrx Biopharma for $2bn

Johnson & Johnson (J&J) has concluded the acquisition of clinical-stage biopharmaceutical company Ambrx Biopharma in a $2bn transaction. The companies…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close